vs
Side-by-side financial comparison of CHART INDUSTRIES INC (GTLS) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
CHART INDUSTRIES INC is the larger business by last-quarter revenue ($1.1B vs $622.0M, roughly 1.7× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 5.0%, a 29.5% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -2.5%). Over the past eight quarters, CHART INDUSTRIES INC's revenue compounded faster (6.6% CAGR vs 4.6%).
Oricon Inc. , established in 1999, is the holding company at the head of a Japanese corporate group that supplies statistics and information on music and the music industry in Japan and Western music. It started as Original Confidence Inc. , which was founded by Sōkō Koike in November 1967 and became known for its music charts. Oricon Inc. was originally set up as a subsidiary of Original Confidence and took over the latter's Oricon record charts in April 2002.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
GTLS vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $622.0M |
| Net Profit | $53.6M | $214.2M |
| Gross Margin | 33.3% | — |
| Operating Margin | 11.6% | 62.4% |
| Net Margin | 5.0% | 34.4% |
| Revenue YoY | -2.5% | 4.8% |
| Net Profit YoY | -32.7% | 2.9% |
| EPS (diluted) | $1.06 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $1.0B | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.0B | $537.3M | ||
| Q1 24 | $950.7M | $568.0M |
| Q4 25 | $53.6M | $214.2M | ||
| Q3 25 | $-138.5M | $288.2M | ||
| Q2 25 | $76.1M | $30.2M | ||
| Q1 25 | $49.5M | $238.3M | ||
| Q4 24 | $79.6M | $208.2M | ||
| Q3 24 | $69.0M | $544.0M | ||
| Q2 24 | $58.6M | $102.0M | ||
| Q1 24 | $11.3M | $4.8M |
| Q4 25 | 33.3% | — | ||
| Q3 25 | 34.1% | — | ||
| Q2 25 | 33.6% | — | ||
| Q1 25 | 33.9% | — | ||
| Q4 24 | 33.6% | — | ||
| Q3 24 | 34.1% | — | ||
| Q2 24 | 33.8% | — | ||
| Q1 24 | 31.8% | — |
| Q4 25 | 11.6% | 62.4% | ||
| Q3 25 | -8.0% | 70.1% | ||
| Q2 25 | 15.7% | 36.3% | ||
| Q1 25 | 15.2% | 94.0% | ||
| Q4 24 | 17.0% | 60.9% | ||
| Q3 24 | 16.8% | — | ||
| Q2 24 | 16.1% | 50.2% | ||
| Q1 24 | 11.9% | -13.0% |
| Q4 25 | 5.0% | 34.4% | ||
| Q3 25 | -12.6% | 47.3% | ||
| Q2 25 | 7.0% | 5.2% | ||
| Q1 25 | 4.9% | 41.9% | ||
| Q4 24 | 7.2% | 35.1% | ||
| Q3 24 | 6.5% | 96.3% | ||
| Q2 24 | 5.6% | 19.0% | ||
| Q1 24 | 1.2% | 0.8% |
| Q4 25 | $1.06 | $0.49 | ||
| Q3 25 | $-3.23 | $0.67 | ||
| Q2 25 | $1.53 | $0.07 | ||
| Q1 25 | $0.94 | $0.55 | ||
| Q4 24 | $1.57 | $0.46 | ||
| Q3 24 | $1.33 | $1.21 | ||
| Q2 24 | $1.10 | $0.23 | ||
| Q1 24 | $0.10 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $366.0M | $618.7M |
| Total DebtLower is stronger | $3.7B | $9.0B |
| Stockholders' EquityBook value | $3.2B | $9.7B |
| Total Assets | $9.8B | $19.6B |
| Debt / EquityLower = less leverage | 1.13× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $366.0M | $618.7M | ||
| Q3 25 | $399.2M | $938.9M | ||
| Q2 25 | $342.3M | $631.9M | ||
| Q1 25 | $296.2M | $1.1B | ||
| Q4 24 | $308.6M | $929.0M | ||
| Q3 24 | $310.2M | $950.1M | ||
| Q2 24 | $247.4M | $1.8B | ||
| Q1 24 | $191.9M | $843.0M |
| Q4 25 | $3.7B | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $3.8B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $3.2B | $9.7B | ||
| Q3 25 | $3.2B | $9.6B | ||
| Q2 25 | $3.4B | $9.5B | ||
| Q1 25 | $3.0B | $9.8B | ||
| Q4 24 | $2.8B | $10.3B | ||
| Q3 24 | $3.0B | $10.3B | ||
| Q2 24 | $2.7B | $9.8B | ||
| Q1 24 | $2.7B | $9.9B |
| Q4 25 | $9.8B | $19.6B | ||
| Q3 25 | $9.8B | $19.3B | ||
| Q2 25 | $9.7B | $18.3B | ||
| Q1 25 | $9.3B | $17.6B | ||
| Q4 24 | $9.1B | $18.2B | ||
| Q3 24 | $9.5B | $18.0B | ||
| Q2 24 | $9.3B | $17.7B | ||
| Q1 24 | $9.2B | $16.1B |
| Q4 25 | 1.13× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 1.33× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $88.8M | $827.1M |
| Free Cash FlowOCF − Capex | $66.2M | — |
| FCF MarginFCF / Revenue | 6.1% | — |
| Capex IntensityCapex / Revenue | 2.1% | — |
| Cash ConversionOCF / Net Profit | 1.66× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $202.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $88.8M | $827.1M | ||
| Q3 25 | $118.0M | $702.6M | ||
| Q2 25 | $145.9M | $364.0M | ||
| Q1 25 | $-60.0M | $596.1M | ||
| Q4 24 | $281.4M | $742.5M | ||
| Q3 24 | $200.6M | $703.6M | ||
| Q2 24 | $116.1M | $658.2M | ||
| Q1 24 | $-95.1M | $664.6M |
| Q4 25 | $66.2M | — | ||
| Q3 25 | $94.7M | — | ||
| Q2 25 | $122.0M | — | ||
| Q1 25 | $-80.1M | — | ||
| Q4 24 | $260.9M | — | ||
| Q3 24 | $174.5M | — | ||
| Q2 24 | $88.0M | — | ||
| Q1 24 | $-141.2M | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 8.6% | — | ||
| Q2 25 | 11.3% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | 23.6% | — | ||
| Q3 24 | 16.4% | — | ||
| Q2 24 | 8.5% | — | ||
| Q1 24 | -14.9% | — |
| Q4 25 | 2.1% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 4.8% | — |
| Q4 25 | 1.66× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 1.92× | 12.06× | ||
| Q1 25 | -1.21× | 2.50× | ||
| Q4 24 | 3.54× | 3.57× | ||
| Q3 24 | 2.91× | 1.29× | ||
| Q2 24 | 1.98× | 6.45× | ||
| Q1 24 | -8.42× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GTLS
| Repair Service And Leasing Segment | $330.4M | 31% |
| Heat Transfer Systems Segment | $325.8M | 30% |
| Specialty Products Segment | $259.5M | 24% |
| Transferred Over Time | $94.4M | 9% |
| Transferred At Point In Time | $69.5M | 6% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
